Quellen:

• Heckman, Melanie A.; Weil, Jorge; Gonzalez de Mejia, Elvira (2010): Caffeine (1, 3, 7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters. In: Journal of food science 75 (3), R77-87. DOI: 10.1111/j.1750-3841.2010.01561.x.
• Temple, Jennifer L.; Bernard, Christophe; Lipshultz, Steven E.; Czachor, Jason D.; Westphal, Joslyn A.; Mestre, Miriam A. (2017): The Safety of Ingested Caffeine: A Comprehensive Review. In: Frontiers in psychiatry 8, S. 80. DOI: 10.3389/fpsyt.2017.00080.
• Glade, Michael J. (2010): Caffeine-Not just a stimulant. In: Nutrition (Burbank, Los Angeles County, Calif.) 26 (10), S. 932–938. DOI: 10.1016/j.nut.2010.08.004.
• https://de.statista.com/statistik/daten/studie/5271/umfrage/pro-kopf-verbrauch-an-heissgetraenken-in-deutschland-seit-2000/
• Wang, Yu; Ho, Chi-Tang (2009): Polyphenolic chemistry of tea and coffee: a century of progress. In: Journal of agricultural and food chemistry 57 (18), S. 8109–8114. DOI: 10.1021/jf804025c.
• https://fdc.nal.usda.gov/index.html
• Hayakawa, Sumio; Ohishi, Tomokazu; Miyoshi, Noriyuki; Oishi, Yumiko; Nakamura, Yoriyuki; Isemura, Mamoru (2020): Anti-Cancer Effects of Green Tea Epigallocatchin-3-Gallate and Coffee Chlorogenic Acid. In: Molecules (Basel, Switzerland) 25 (19). DOI: 10.3390/molecules25194553.
• Zhong, Yanchun; Ding, Yueling; Li, Laiqing; Ge, Meina; Ban, Guangguo; Yang, Hongxia et al. (2020): Effects and Mechanism of Chlorogenic Acid on Weight Loss. In: Current pharmaceutical biotechnology 21 (11), S. 1099–1106. DOI: 10.2174/1389201021666200318124922.
• Choi, Cheoljun; Song, Hyun-Doo; Son, Yeonho; Cho, Yoon Keun; Ahn, Sang-Yeop; Jung, Young-Suk et al. (2020): Epigallocatechin-3-Gallate Reduces Visceral Adiposity Partly through the Regulation of Beclin1-Dependent Autophagy in White Adipose Tissues. In: Nutrients 12 (10). DOI: 10.3390/nu12103072.
• Jee, S. H.; He, J.; Appel, L. J.; Whelton, P. K.; Suh, I.; Klag, M. J. (2001): Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. In: Am J Epidemiol 153 (4), S. 353–362. DOI: 10.1093/aje/153.4.353.

Kontakt: info@janek-jungkeit.de